Chitinase-like Protein and Asthma

Authors:

Abstract
In their descriptive study of a chitinase-like protein in patients with asthma, Chupp et al. (Nov. 15 issue)1 report elevated levels of YKL-40 (human cartilage glycoprotein 39 and chitinase 3–like 1) in the serum and lungs of patients with asthma. We measured YKL-40 concentrations in serum before and 24 hours after segmental allergen challenge,2 as well as in bronchoalveolar-lavage fluid 10 minutes and 24 hours after segmental allergen challenge, in 13 patients with allergic asthma, using the same enzyme-linked immunosorbent assay (Quidel). YKL-40 concentrations were significantly elevated in serum (P=0.01) and even more elevated in bronchoalveolar-lavage fluid (P=0.003) 24 hours after allergen challenge ( Table 1 ). In addition, levels of YKL-40 in bronchoalveolar-lavage fluid were positively correlated with eosinophil counts 24 hours after allergen challenge (rS=0.768, P=0.002). Although the pathogenetic role of YKL-40 in asthma remains unclear, we extend the data from Chupp et al.1 by showing that YKL-40 concentrations increase in response to allergen challenge predominantly at the site of allergen deposition.

This publication has 2 references indexed in Scilit: